Effect of Xenogeneic Collagen Matrix on the Peri-implant Tissues of Immediate Implants.
Launched by UNIVERSITAT INTERNACIONAL DE CATALUNYA · Jul 18, 2021
Trial Information
Current as of May 29, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Adequate oral hygiene (21).
- • 2. Sufficient interocclusal space (≥6 mm) to place a provisional crown without occlusion.
- • 3. Presence of adjacent teeth. Only one tooth gap.
- • 4. Presence of soft tissue and cortical buccal bone of the tooth to be extracted according to the classification of Elian et al. 2007
- • 5. Adequate bone quantity in the apical region of the tooth to be extracted (assessed on the CBCT).
- Exclusion Criteria:
- • 1. Patients with medical conditions that affect bone and soft tissue metabolism.
- • 2. Uncontrolled endocrine disorders.
- • 3. Alcohol and drug abuse.
- • 4. Previous history of immunodeficiency syndromes.
- • 5. Patients who smoke\> 10 cigarettes a day.
- • 6. Active periodontal disease.
- • 7. Absence of a tooth adjacent to the tooth to be treated.
- • 8. Oral lesions of the untreated mucosa.
- • 9. Recent previous history (\<6 months) of local radiotherapy or chemotherapy.
- • 10. Bruxism or severe parafunctions.
- • 11. Pregnant patients.
About Universitat Internacional De Catalunya
The Universitat Internacional de Catalunya (UIC) is a prestigious higher education institution situated in Barcelona, Spain, renowned for its commitment to academic excellence and innovation in research. With a strong emphasis on interdisciplinary collaboration, UIC actively engages in clinical trials that aim to advance medical knowledge and improve patient outcomes. The university's dedicated research teams are equipped with cutting-edge facilities and experienced professionals, enabling them to conduct rigorous studies across various health-related fields. UIC's focus on ethical practices and compliance ensures that all clinical trials are conducted with the highest standards of scientific integrity and participant safety.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Barcelona, , Spain
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials